Table 2.
Malignancy | CD150/SLAM (Ref/Evidence) | CD46/Membrane Cofactor Protein (Ref/Evidence) |
Nectin-4 (Ref/Evidence) |
---|---|---|---|
Breast cancer | [39]/IS, [14,15,16]/IS, TCGA dataset | [33,40,41,42,43,44,45]/IS, FC, PCR | |
Cervical cancer | [14,15,16]/IS, TCGA dataset | ||
Colorectal cancer | [14,15,16]/IS, TCGA dataset, [46]/oligo-array | [14,15,16,33,45,46]/IS, TCGA dataset | |
Endometrial cancer | [14,15,16]/IS, TCGA dataset | ||
Glioma | [47] IS, FC | ||
Liver cancer | [14,15,16]/IS, TCGA dataset | [48]/PCR, IS | |
Lung cancer | [33,49]/IS, ELISA | ||
Non-small cell lung cancer | [50] IS, FC | [46]/Oligo-array | |
Lymphoma | [51]/PCR, IS, WB, FC | [52] IS, FC | |
Melanoma | [14,15,16]/IS, TCGA | ||
Multiple myeloma | [53]/IS, [46]/Oligo-array | ||
Ovarian cancer | [54]/IS, WB | [55,56]/PCR, IS, WB, FC | |
Pancreatic cancer | [14,15,16]/IS, TCGA dataset | [57]/IS | |
Prostate cancer | |||
Stomach cancer | |||
Thyroid cancer | [14,15,16]/IS, TCGA dataset | ||
Urothelial cancer | [14,15,16]/IS, TCGA dataset |
Abbreviations: IS: Immunohistochemical staining; FC: Flow Cytometry; PCR: Quantitative RT-PCR; TCGA: Tissue Cancer Genome Atlas; WB: Western immunoblotting.